Vol. 32, Issue 1, 2022March 01, 2022 PDT
AAM V. ROBERT BONTA: AN END TO CALIFORNIA PHARMACEUTICAL LEGISLATIVE REFORM?
AAM V. ROBERT BONTA: AN END TO CALIFORNIA PHARMACEUTICAL LEGISLATIVE REFORM?
Seth Silber, Alexander Poonai,
Articles in Vol. 32, Issue 1, 2022
Vol. 32, Issue 1, 2022
- RECENT DEVELOPMENTS IN ANTITRUST AND UNFAIR COMPETITION LAWMalinda Lee
- BIG STAKES ANTITRUST TRIAL: IN RE NATIONAL COLLEGIATE ATHLETIC ASSOCIATION ATHLETIC GRANT-INAID CAP ANTITRUST LITIGATIONAaron M. Sheanin
- BIG STAKES MERGER: FEDERAL TRADE COMMISSION, ET AL. V. THOMAS JEFFERSON UNIVERSITY, ET AL.Shira Liu
- VIEWS FROM THE TOP: MANAGING ANTITRUST PRACTICE IN CHANGING TIMESJiamie Chen
- A CONVERSATION WITH CALIFORNIA SUPREME COURT JUSTICE MARTIN J. JENKINSPaul Moore
- COMBATTING COVID THROUGH . . . CONSUMER PROTECTION? A MULTIJURISDICTIONAL APPROACH TO PROTECTING PUBLIC HEALTH THROUGH ENFORCEMENT OF CONSUMER FRAUD LAWSChristina TusanWilliam PletcherAlex Bergjans
- AAM V. ROBERT BONTA: AN END TO CALIFORNIA PHARMACEUTICAL LEGISLATIVE REFORM?Seth SilberAlexander Poonai
- NO-POACH AGREEMENTS: INCREASINGLY RISKYLaura K. Kaufmann
Seth Silber & Alexander Poonai, AAM V. ROBERT BONTA: AN END TO CALIFORNIA PHARMACEUTICAL LEGISLATIVE REFORM?, 32 Competition Journal (2022).